International Journal of Cancer, 140(6), 1317. Wiley-Liss Inc. Fortner, R T, Hüsing, A, Kühn, T, Konar, M, Overvad, K, Tjønneland, A, Hansen, L, Boutron-Ruault, M-C, Severi, G, Fournier, A, Boeing, H, Trichopoulou, A, Benetou, V, Orfanos, P, Masala, G, Agnoli, C, Mattiello, A, Tumino, R, Sacerdote, C, Bueno-de-Mesquita, H B A, Peeters, P H M, Weiderpass, E, Gram, I T, Gavrilyuk, O, Quirós, J R, Huerta, J M, Ardanaz, E, Larrañaga, N, Lujan-Barroso, L, Sánchez-Cantalejo, E, Butt, S T, Borgquist, S, Idahl, A, Lundin, E, Khaw, K-T, Allen, N E, Rinaldi, S, Dossus, L, Gunter, M, Merritt, M A, Tzoulaki, I, Riboli, E & Kaaks, R 2017, ' Endometrial cancer risk prediction including serum-based biomarkers : Results from the EPIC cohort ', International Journal of Cancer, vol. 140, no. 6, pp. 1317-1323 . https://doi.org/10.1002/ijc.30560